{"id":"https://openalex.org/W4408031363","doi":"https://doi.org/10.1016/s2213-8587(24)00377-2","title":"Efficacy and safety of once-weekly tirzepatide in Japanese patients with obesity disease (SURMOUNT-J): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial","display_name":"Efficacy and safety of once-weekly tirzepatide in Japanese patients with obesity disease (SURMOUNT-J): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial","publication_year":2025,"publication_date":"2025-02-28","ids":{"openalex":"https://openalex.org/W4408031363","doi":"https://doi.org/10.1016/s2213-8587(24)00377-2","pmid":"https://pubmed.ncbi.nlm.nih.gov/40031941"},"language":"en","primary_location":{"id":"doi:10.1016/s2213-8587(24)00377-2","doi":"https://doi.org/10.1016/s2213-8587(24)00377-2","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2213-8587(24)00377-2","pdf_url":null,"source":{"id":"https://openalex.org/S2529869117","display_name":"The Lancet Diabetes & Endocrinology","issn_l":"2213-8587","issn":["2213-8587","2213-8595"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Diabetes & Endocrinology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040548657","display_name":"Takashi Kadowaki","orcid":"https://orcid.org/0000-0002-5428-3582","observed_orcids":["https://orcid.org/0000-0002-5428-3582"]},"institutions":[{"id":"https://openalex.org/I4210166463","display_name":"Toranomon Hospital","ror":"https://ror.org/05rkz5e28","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210166463"]},{"id":"https://openalex.org/I4405257210","display_name":"Federation of National Public Service Personnel Mutual Aid Associations","ror":"https://ror.org/050ybep11","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405257210"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takashi Kadowaki","raw_affiliation_strings":["Toranomon Hospital, Federation of National Public Service Personnel Mutual Aid Associations, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Toranomon Hospital, Federation of National Public Service Personnel Mutual Aid Associations, Tokyo, Japan","institution_ids":["https://openalex.org/I4210166463","https://openalex.org/I4405257210"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068421637","display_name":"Arihiro Kiyosue","orcid":"https://orcid.org/0000-0003-3201-7846","observed_orcids":["https://orcid.org/0000-0003-3201-7846"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arihiro Kiyosue","raw_affiliation_strings":["Moriyama Memorial Hospital, Cardiovascular Center, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moriyama Memorial Hospital, Cardiovascular Center, Tokyo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041854551","display_name":"Tomotaka Shingaki","orcid":"https://orcid.org/0000-0003-1568-9763","observed_orcids":["https://orcid.org/0000-0003-1568-9763"]},"institutions":[{"id":"https://openalex.org/I4210108315","display_name":"Eli Lilly (Japan)","ror":"https://ror.org/01sv7f575","country_code":"JP","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210108315"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Tomotaka Shingaki","raw_affiliation_strings":["Japan Drug Development and Medical Affairs, Eli Lilly Japan, Kobe, Japan. Electronic address: shingaki_tomotaka@lilly.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Drug Development and Medical Affairs, Eli Lilly Japan, Kobe, Japan. Electronic address: shingaki_tomotaka@lilly.com","institution_ids":["https://openalex.org/I4210108315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065510246","display_name":"Tomonori Oura","orcid":"https://orcid.org/0000-0003-0872-8576","observed_orcids":["https://orcid.org/0000-0003-0872-8576"]},"institutions":[{"id":"https://openalex.org/I4210108315","display_name":"Eli Lilly (Japan)","ror":"https://ror.org/01sv7f575","country_code":"JP","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210108315"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomonori Oura","raw_affiliation_strings":["Japan Drug Development and Medical Affairs, Eli Lilly Japan, Kobe, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Drug Development and Medical Affairs, Eli Lilly Japan, Kobe, Japan","institution_ids":["https://openalex.org/I4210108315"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079640536","display_name":"Koutaro Yokote","orcid":"https://orcid.org/0000-0003-3033-4813","observed_orcids":["https://orcid.org/0000-0003-3033-4813"]},"institutions":[{"id":"https://openalex.org/I159385669","display_name":"Chiba University","ror":"https://ror.org/01hjzeq58","country_code":"JP","type":"education","lineage":["https://openalex.org/I159385669"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Koutaro Yokote","raw_affiliation_strings":["Chiba University, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chiba University, Chiba, Japan","institution_ids":["https://openalex.org/I159385669"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5041854551"],"corresponding_institution_ids":["https://openalex.org/I4210108315"],"apc_list":{"value":7280,"currency":"USD","value_usd":7280},"apc_paid":null,"fwci":27.3755,"has_fulltext":false,"cited_by_count":54,"citation_normalized_percentile":{"value":0.99845149,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"13","issue":"5","first_page":"384","last_page":"396"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10569","display_name":"Bariatric Surgery and Outcomes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tirzepatide","display_name":"tirzepatide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.9169999957084656},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.7689999938011169},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.7870000004768372},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.828000009059906},{"id":"https://openalex.org/keywords/gip-receptor-agonist","display_name":"GIP receptor agonist","score":0.7350000143051147},{"id":"https://openalex.org/keywords/obesity-related-comorbidities","display_name":"obesity-related comorbidities","score":0.7120000123977661},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.6959999799728394},{"id":"https://openalex.org/keywords/asian-patients","display_name":"Asian patients","score":0.4009999930858612},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.4880000054836273},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.7910000085830688},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5389999747276306},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.5640000104904175},{"id":"https://openalex.org/keywords/pharmacoeconomics","display_name":"pharmacoeconomics","score":0.3109999895095825}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9618521928787231},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7394477128982544},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.5663150548934937},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.4922083914279938},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4501195549964905},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.4471099376678467},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.43750548362731934},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.32794421911239624},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.32691723108291626},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30469653010368347},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.045054078102111816}],"mesh":[{"descriptor_ui":"D000095225","descriptor_name":"East Asian People","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000098860","descriptor_name":"Tirzepatide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000098860","descriptor_name":"Tirzepatide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000098860","descriptor_name":"Tirzepatide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015431","descriptor_name":"Weight Loss","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019440","descriptor_name":"Anti-Obesity Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D019440","descriptor_name":"Anti-Obesity Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D019440","descriptor_name":"Anti-Obesity Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/s2213-8587(24)00377-2","doi":"https://doi.org/10.1016/s2213-8587(24)00377-2","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2213-8587(24)00377-2","pdf_url":null,"source":{"id":"https://openalex.org/S2529869117","display_name":"The Lancet Diabetes & Endocrinology","issn_l":"2213-8587","issn":["2213-8587","2213-8595"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Diabetes & Endocrinology","raw_type":"journal-article"},{"id":"pmid:40031941","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40031941","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The lancet. Diabetes & endocrinology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320333624","display_name":"Eli Lilly Japan","ror":"https://ror.org/01sv7f575"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W807162506","https://openalex.org/W1798757189","https://openalex.org/W1985392716","https://openalex.org/W2053915733","https://openalex.org/W2106184606","https://openalex.org/W2462595066","https://openalex.org/W2515972405","https://openalex.org/W2573605132","https://openalex.org/W2953396318","https://openalex.org/W2985579744","https://openalex.org/W3017212504","https://openalex.org/W3049084794","https://openalex.org/W3108676144","https://openalex.org/W4210417346","https://openalex.org/W4211009683","https://openalex.org/W4211170672","https://openalex.org/W4224257527","https://openalex.org/W4281934192","https://openalex.org/W4288735703","https://openalex.org/W4288740467","https://openalex.org/W4366769762","https://openalex.org/W4382050932","https://openalex.org/W4387653463","https://openalex.org/W4389555309","https://openalex.org/W4389961530","https://openalex.org/W4391544369","https://openalex.org/W4399208325"],"related_works":["https://openalex.org/W7126226000","https://openalex.org/W4411138537","https://openalex.org/W4416670806","https://openalex.org/W4281934192","https://openalex.org/W4286457141","https://openalex.org/W4399208325","https://openalex.org/W4382050932","https://openalex.org/W7160952297","https://openalex.org/W7168015349","https://openalex.org/W7164757603"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":37},{"year":2025,"cited_by_count":17}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-03-01T00:00:00"}